期刊
ORGANIC & BIOMOLECULAR CHEMISTRY
卷 9, 期 4, 页码 1140-1147出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c0ob00393j
关键词
-
资金
- European FP6 EU-RAMY project
The multifaceted nature of Alzheimer's disease (AD) has led to the development of multi-targeted compounds based on the classical AD drug, tacrine, first known to inhibit the acetylcholine-degrading enzyme acetylcholinesterase (AChE). In the present work, we explore the potentiality of multimers of tacrine in this field. The synthesis using the so-called click chemistry and the in vitro study of the conjugates are described. Two or four copies of the tacrine molecule are clicked on a constrained cyclopeptide template proven to be a convenient tool for multimeric presentation. The multimers significantly inhibit self-induced amyloid fibril formation from A beta(40) at low inhibitor to A beta molar ratios at which the tacrine monomer is fully inactive (Thioflavin T assays and AFM observation). Moreover, they have the capacity to bind to A beta(40) fibrils (SPR assays) while retaining the AChE inhibitory activity of the parent tacrine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据